Malaysia. The Malaysian Adverse Reactions Advisory Committee (MADRAC) reports that the Drug Control Authority (DCA) in Malaysia has decided to extend its December 2001 withdrawal of products containing acetone-extract kava to include all products containing kava. Regulatory decisions on kava products taken elsewhere in the world may be referred to in previous issues of the WHO Pharmaceuticals Newsletter.

Reference:
MADRAC News, Berita Ubat-ubatan 19:8-9, Aug 2002.